Search Results

There are 15137 results for: content related to: The potential value of monitoring bone turnover markers among women on alendronate

  1. Prazosin + Naltrexone Decreases Alcohol Drinking More Effectively Than Does Either Drug Alone in P Rats with a Protracted History of Extensive Voluntary Alcohol Drinking, Dependence, and Multiple Withdrawals

    Alcoholism: Clinical and Experimental Research

    Volume 39, Issue 9, September 2015, Pages: 1832–1841, Dennis D. Rasmussen, Carrie L. Kincaid and Janice C. Froehlich

    Version of Record online : 11 AUG 2015, DOI: 10.1111/acer.12828

  2. You have free access to this content
    Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acid

    Cancer

    Volume 113, Issue 1, 1 July 2008, Pages: 193–201, Allan Lipton, Richard Cook, Fred Saad, Pierre Major, Patrick Garnero, Evangelos Terpos, Janet E. Brown and Robert E. Coleman

    Version of Record online : 5 MAY 2008, DOI: 10.1002/cncr.23529

  3. Development of Naltrexone Supersensitivity During Food-Maintained Responding Enhances Naltrexone's Ability to Reduce Ethanol-Maintained Responding

    Alcoholism: Clinical and Experimental Research

    Volume 31, Issue 1, January 2007, Pages: 39–47, Keith L. Williams

    Version of Record online : 15 DEC 2006, DOI: 10.1111/j.1530-0277.2006.00272.x

  4. You have full text access to this OnlineOpen article
    A pharmaceutical industry perspective on the economics of treatments for alcohol and opioid use disorders

    Annals of the New York Academy of Sciences

    Volume 1327, Issue 1, October 2014, Pages: 112–130, David R. Gastfriend

    Version of Record online : 18 SEP 2014, DOI: 10.1111/nyas.12538

  5. Specific and Nonspecific Effects of Naltrexone on Goal-Directed and Habitual Models of Alcohol Seeking and Drinking

    Alcoholism: Clinical and Experimental Research

    Volume 37, Issue 7, July 2013, Pages: 1100–1110, Rachel A. Hay, Joshua H. Jennings, Dawnya L. Zitzman, Clyde W. Hodge and Donita L. Robinson

    Version of Record online : 7 FEB 2013, DOI: 10.1111/acer.12081

  6. You have free access to this content
    ASBMR 27th Annual Meeting M001–M525

    Journal of Bone and Mineral Research

    Volume 20, Issue S1, 11 August 2005, Pages: S313–S437,

    Version of Record online : 16 JUN 2011, DOI: 10.1002/jbmr.5650201306

  7. Phase I trial of Seneca Valley Virus (NTX-010) in children with relapsed/refractory solid tumors: A report of the Children's Oncology Group

    Pediatric Blood & Cancer

    Volume 62, Issue 5, May 2015, Pages: 743–750, Michael J. Burke, Charlotte Ahern, Brenda J. Weigel, John T. Poirier, Charles M. Rudin, Yingbei Chen, Timothy P. Cripe, M. Brooke Bernhardt and Susan M. Blaney

    Version of Record online : 12 OCT 2014, DOI: 10.1002/pbc.25269

  8. Nontraditional crops, traditional constraints: The long-term welfare impacts of export crop adoption among Guatemalan smallholders

    Agricultural Economics

    Volume 42, Issue s1, November 2011, Pages: 61–76, Calogero Carletto, Talip Kilic and Angeli Kirk

    Version of Record online : 10 NOV 2011, DOI: 10.1111/j.1574-0862.2011.00552.x

  9. Intramuscular extended-release naltrexone: current evidence

    Annals of the New York Academy of Sciences

    Volume 1216, Issue 1, January 2011, Pages: 144–166, David R. Gastfriend

    Version of Record online : 27 JAN 2011, DOI: 10.1111/j.1749-6632.2010.05900.x

    Corrected by:

    Corrigendum for Ann. N. Y. Acad. Sci. 1216: 144–166

    Vol. 1224, Issue 1, 207, Version of Record online: 12 APR 2011

  10. Naltrexone salt selection for enhanced transdermal permeation through microneedle-treated skin

    Journal of Pharmaceutical Sciences

    Volume 101, Issue 8, August 2012, Pages: 2777–2786, Mikolaj Milewski, Raghotham R. Pinninti and Audra L. Stinchcomb

    Version of Record online : 24 MAY 2012, DOI: 10.1002/jps.23189

  11. You have free access to this content
    Progression of autoimmune hepatitis is mediated by IL-18-producing dendritic cells and hepatic CXCL9 expression in mice

    Hepatology

    Volume 60, Issue 1, July 2014, Pages: 224–236, Aki Ikeda, Nobuhiro Aoki, Masahiro Kido, Satoru Iwamoto, Hisayo Nishiura, Ryutaro Maruoka, Tsutomu Chiba and Norihiko Watanabe

    Version of Record online : 28 MAY 2014, DOI: 10.1002/hep.27087

  12. Alcohol Consumption Is Enhanced After Naltrexone Treatment

    Alcoholism: Clinical and Experimental Research

    Volume 31, Issue 2, February 2007, Pages: 260–264, Jorge Juárez and Barrios De Tomasi Eliana

    Version of Record online : 18 JAN 2007, DOI: 10.1111/j.1530-0277.2006.00313.x

  13. Enhanced skin permeation of naltrexone by pulsed electromagnetic fields in human skin in vitro

    Journal of Pharmaceutical Sciences

    Volume 99, Issue 6, June 2010, Pages: 2724–2731, Gayathri Krishnan, Jeffrey Edwards, Yan Chen and Heather A.E. Benson

    Version of Record online : 14 DEC 2009, DOI: 10.1002/jps.22024

  14. Effects of Naltrexone on Neural and Subjective Response to Alcohol in Treatment-Seeking Alcohol-Dependent Patients

    Alcoholism: Clinical and Experimental Research

    Volume 38, Issue 12, December 2014, Pages: 3024–3032, Primavera A. Spagnolo, Vijay A. Ramchandani, Melanie L. Schwandt, Lishu Zhang, Sara K. Blaine, Julie M. Usala, Kristie A. Diamond, Monte J. Phillips, David T. George, Reza Momenan and Markus Heilig

    Version of Record online : 7 JAN 2015, DOI: 10.1111/acer.12581

  15. Bone Resorption Markers and Dual-Energy X-Ray Absorptiometry in Dogs with Avascular Necrosis, Degenerative Joint Disease, and Trauma of the Coxofemoral Joint

    Veterinary Surgery

    Volume 41, Issue 5, July 2012, Pages: 551–558, David Youkhanna, Dominique J. Griffon, Page Fredericks, David Schaeffer, Timothy M. Fan and Iwona M. Jasiuk

    Version of Record online : 18 MAY 2012, DOI: 10.1111/j.1532-950X.2011.00991.x

  16. Injectable extended-release naltrexone (XR-NTX) for opioid dependence: long-term safety and effectiveness

    Addiction

    Volume 108, Issue 9, September 2013, Pages: 1628–1637, Evgeny Krupitsky, Edward V. Nunes, Walter Ling, David R. Gastfriend, Asli Memisoglu and Bernard L. Silverman

    Version of Record online : 24 MAY 2013, DOI: 10.1111/add.12208

  17. Fluvastatin as a Micropore Lifetime Enhancer for Sustained Delivery Across Microneedle-Treated Skin

    Journal of Pharmaceutical Sciences

    Volume 103, Issue 2, February 2014, Pages: 652–660, Priyanka Ghosh, Nicole K. Brogden and Audra L. Stinchcomb

    Version of Record online : 6 JAN 2014, DOI: 10.1002/jps.23844

  18. Naltrexone attenuates amphetamine-induced locomotor sensitization in the rat

    Addiction Biology

    Volume 16, Issue 1, January 2011, Pages: 20–29, Jenny Häggkvist, Carl Björkholm, Pia Steensland, Sara Lindholm, Johan Franck and Björn Schilström

    Version of Record online : 26 FEB 2010, DOI: 10.1111/j.1369-1600.2009.00199.x

  19. Bupropion and naltrexone for smoking cessation: A double-blind randomized placebo-controlled clinical trial

    Clinical Pharmacology & Therapeutics

    ME Mooney, JM Schmitz, S Allen, J Grabowski, P Pentel, A Oliver and DK Hatsukami

    Version of Record online : 20 JUN 2016, DOI: 10.1002/cpt.402

  20. Hepatic Safety of Once-Monthly Injectable Extended-Release Naltrexone Administered to Actively Drinking Alcoholics

    Alcoholism: Clinical and Experimental Research

    Volume 32, Issue 3, March 2008, Pages: 498–504, Michael R. Lucey, Bernard L. Silverman, Ari Illeperuma and Charles P. O’Brien

    Version of Record online : 30 JAN 2008, DOI: 10.1111/j.1530-0277.2007.00593.x